Tyrosine kinase inhibitor and vascular adverse events in chronic myeloid leukemia patients: a population‐based, propensity score‐matched cohort study
2015 ◽
Vol 8
(4)
◽
pp. 457-479
◽
2017 ◽
Vol 10
(7)
◽
pp. 583-586
◽
2013 ◽
Vol 13
(7)
◽
pp. 755-767
◽